A Cyclodiaryliodonium NOX Inhibitor for the Treatment of Pancreatic Cancer via Enzyme‐Activatable Targeted Delivery by Sulfated Glycosaminoglycan Derivatives (Adv. Healthcare Mater. 17/2023)
Open Access
- 6 July 2023
- journal article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 12 (17)